Princeton, NJ, United States of America

Zhengxian Gu

This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Ptc Therapeutics, Inc., Ptc Therpeutics, Inc.. Active years: 2011-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhengxian Gu. Retrieved from https://idiyas.com/inventor/zhengxian-gu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 16.7

 

 

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 26(Granted Patents)


Location History:

  • Princeton, NJ (US) (2011 - 2016)
  • Shanghai, CN (2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Zhengxian Gu

Introduction

Zhengxian Gu is a notable inventor based in Princeton, NJ (US), recognized for his significant contributions to the fields of virology and oncology. With a total of six patents to his name, Gu has developed innovative methods and compounds aimed at combating viral infections and treating cancer.

Latest Patents

Among his latest patents, Gu has described a method of inhibiting or reducing viral infections. This includes compounds that inhibit viral replication or the production of viral RNA, DNA, or proteins. The methods outlined involve treating viral infections, particularly those caused by RNA viruses from the family Coronaviridae. The compounds can be administered as a single agent therapy or in combination with other therapies to patients in need. Additionally, Gu has developed methods for treating cancer and non-neoplastic conditions. These involve compounds that selectively inhibit the pathological production of human vascular endothelial growth factor (VEGF). The administration of these compounds can also be combined with other therapies to enhance treatment efficacy.

Career Highlights

Zhengxian Gu has worked with prominent companies such as PTC Therapeutics, Inc. His work has significantly impacted the development of therapeutic strategies for viral infections and cancer treatment. His innovative approaches have paved the way for new treatment modalities that address critical health challenges.

Collaborations

Throughout his career, Gu has collaborated with esteemed colleagues, including Frederick C. Lahser and Jeffrey Allen Campbell. These collaborations have contributed to the advancement of research and development in his areas of expertise.

Conclusion

Zhengxian Gu's work exemplifies the spirit of innovation in the medical field. His patents and research continue to influence the development of effective treatments for viral infections and cancer. His contributions are a testament to the importance of scientific research in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…